Friedman BioVentures
Overview
Friedman BioVentures is a venture capital firm and family office investment arm that invests in early-stage biotechnology and pharmaceutical companies with a focus on platform technologies, oncology, neurodegenerative disease, and genomics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MedCrypt | Jun 2018 | Seed | Co-investor |
| TRIO Pharmaceuticals, Inc. | Mar 2023 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Friedman BioVentures based?
Friedman BioVentures is headquartered in San Diego, California, United States.
When was Friedman BioVentures founded?
Friedman BioVentures was founded in 2012.
How many portfolio companies does Friedman BioVentures have?
Friedman BioVentures has 2 portfolio companies in Caplight's dataset.
What are some companies in Friedman BioVentures's portfolio?
Portfolio companies visible on Caplight include MedCrypt, TRIO Pharmaceuticals, Inc..
What was Friedman BioVentures's most recent investment shown here?
Friedman BioVentures's most recent investment in this portfolio sample was in TRIO Pharmaceuticals, Inc. in 2023.
What sectors does Friedman BioVentures focus on?
Friedman BioVentures focuses on Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences.
What company stages does Friedman BioVentures focus on?
Friedman BioVentures typically invests at the Early stage.